Boone Capital Management LLC
Boone Capital Management LLC reported 16 US-listed holdings worth $427.5 million in its 13F for the quarter ended 30 June 2026, filed 14 August 2026. Its largest: Teleflex Inc. (11.5%), Mirum Pharmaceuticals Inc. (11.4%) and Cigna Group (10.3%). Against the quarter before, it opened 7 positions, added to 8, trimmed 1 and sold out of 4.
The 14 largest of its 16 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.
What the fund reported holding at each quarter's end; hover a bar for the number of positions
What its reported holdings returned
Held through each quarter, the holdings it reported returned +24.8% over the 7 quarters to 30 June 2026, against +30.2% for the S&P 500.
Not the fund's own return: each 13F's holdings are kept unchanged until the next one, so trades inside a quarter, dividends, cash and fees are left out. A rough guide to how its picks have done over time.
What it did on the quarter
Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held
Opened 7
- Vestis Corp. VSTS$27.6 million
- Pennant Group Inc. PNTG$19.1 million
- Monte Rosa Therapeutics Inc. GLUE$14.9 million
- Tango Therapeutics Inc. TNGX$14.2 million
- Kymera Therapeutics Inc. KYMR$13.0 million
- Cullinan Therapeutics Inc. CGEM$12.8 million
- Adlai Nortye Ltd ANL$3.0 million
Added to 8
- Teleflex Inc. TFX+108,596 shares · +39%
- Bridgebio Pharma Inc. BBIO+110,891 shares · +48%
- Cigna Group CI+21,768 shares · +16%
- UnitedHealth Group Inc. UNH+9,461 shares · +12%
- Kodiak Sciences Inc. KOD+96,678 shares · +34%
- Guardian Pharmacy Svcs Inc. GRDN+80,746 shares · +13%
- Biomarin Pharmaceutical Inc. BMRN+35,348 shares · +6%
- Ionis Pharmaceuticals Inc. IONS+19,455 shares · +4%
Trimmed 1
- Mirum Pharmaceuticals Inc. MIRM-5,595 shares · -1%
Sold out of 4
- Medtronic plc MDT$34.5 million last quarter
- AstraZeneca PLC AZN$21.7 million last quarter
- Avanos Med Inc. AVNS$16.6 million last quarter
- Tenax Therapeutics Inc. TENX$3.2 million last quarter
What it holds
| Company | Shares | Value | Of its book | Change in shares |
|---|---|---|---|---|
| Teleflex Inc. TFX | 387.4K | $49.1 million | 11.49% | +108.6K |
| Mirum Pharmaceuticals Inc. MIRM | 415.6K | $48.7 million | 11.38% | -5.6K |
| Cigna Group CI | 159.3K | $43.9 million | 10.27% | +21.8K |
| Ionis Pharmaceuticals Inc. IONS | 520.0K | $41.2 million | 9.64% | +19.5K |
| UnitedHealth Group Inc. UNH | 88.7K | $36.9 million | 8.62% | +9.5K |
| Biomarin Pharmaceutical Inc. BMRN | 583.2K | $33.4 million | 7.81% | +35.3K |
| Guardian Pharmacy Svcs Inc. GRDN | 711.9K | $29.8 million | 6.97% | +80.7K |
| Vestis Corp. VSTS | 1.9M | $27.6 million | 6.45% | new |
| Bridgebio Pharma Inc. BBIO | 339.7K | $25.3 million | 5.92% | +110.9K |
| Pennant Group Inc. PNTG | 515.8K | $19.1 million | 4.46% | new |
| Monte Rosa Therapeutics Inc. GLUE | 615.3K | $14.9 million | 3.48% | new |
| Kodiak Sciences Inc. KOD | 378.0K | $14.7 million | 3.44% | +96.7K |
| Tango Therapeutics Inc. TNGX | 455.6K | $14.2 million | 3.33% | new |
| Kymera Therapeutics Inc. KYMR | 113.2K | $13.0 million | 3.04% | new |
| Cullinan Therapeutics Inc. CGEM | 704.4K | $12.8 million | 3.00% | new |
| Adlai Nortye Ltd ANL | 258.4K | $3.0 million | 0.70% | new |